PPH Legal Blog

A Philadelphia jury gave a defense verdict a few weeks ago in one of the last mass tort cases brought against a diet drug company.
Danny Crowder of Texas brought a lawsuit against Wyeth, which was formerly American Home Products, claiming that his wife’s death was a direct result of diet pills manufactured by this company.
Crowder’s […]

[Read more →]

In early July, GeneraMedix was approved by the FDA for its Epoprostenol for injection 1.5mg drug. GeneraMedix’s Epoprostenol for injection 1.5mg is meant to be a long-term intravenous treatment for primary pulmonary hypertension (PPH).
PHH is caused by the thinning or narrowing of the blood vessels that supply the lungs. If left untreated, an individual’s blood […]

[Read more →]

After eight long weeks, the trial of Gallion and Cunningham ended in a mistrial due to a deadlocked jury. Their partner, Melbourne Mills, was acquitted before the jury became stuck on the charges against the former two. All three attorneys were accused of stealing $65 million dollars from the $200 million dollar lawsuit filed by […]

[Read more →]

In the final stages of the trial, the lawyer-defendants involved in the Fen-phen trial called an adverse witness, class action guru Stanley Chesley, to testify on their behalf.   This move appears as a last ditch effort for the lawyer-defendants who lack experts willing to testify in their favor.
Chesley testified that he had been hired by […]

[Read more →]

In the recent trial of three prominent lawyers accused of taking $65 million from their clients’ lawsuit against makers of the diet drug Fen-phen, the defendant Melbourne Mills Jr. was recently hospitalized, delaying the trial.  In addition to the financial theft from their clients’ $200 million settlement, each of the lawyers is also accused of […]

[Read more →]